#prevention #clinicaltrials #cohorts #drugdiscovery #riskfactors #neuroimaging #pharmacology #exercise #nutrition #pollution #nursing #psychiatry #immunology #lifestyle #psychology #cognition #healthyageing #livingwell #stroke #mentalhealth #wayfinding
Craig is the Professor of Psychiatry of Ageing at the University of Edinburgh, Director of Edinburgh Dementia Prevention and Director of Brain Health Scotland.
Craig is internationally renowned for his work on the design and prosecution of clinical trials. He has been Principal Investigator for almost 30 commercial trials in Alzheimer’s disease, National Chief Investigator for 15 in the UK and Global Coordinating Investigator on 6.
Craig’s research focuses on early detection of disease and the promotion of brain health throughout the life-course to mitigate risks for development and progression of brain diseases that lead to dementia.
Craig is Chair of the Scottish Dementia Research Consortium (SDRC) and Chief Investigator of the European Prevention of Alzheimer’s Dementia (EPAD) Consortium and the PREVENT Dementia Programme.
Prof Craig Ritchie
Dr Mario Parra Rodriguez
Mario is a Lecturer in Psychology at the University of Strathclyde, Glasgow and member of the Scottish Dementia Research Consortium Executive Committee.
Mario graduated as a Medical Doctor in 1993 and as a Clinical Neurophysiologist in 1997. He worked at the Cuban Neuroscience Centre and at different University Hospitals in Cuba and in Colombia. During his clinical work he focused on neuropsychological and neurophysiological aspects of dementia syndromes and other neurological disorders and taught neuroscience related subjects in the field of medicine and psychology.
Mario's motivation for teaching and research led me to a major career change into academia. This started with his PhD in 2005 at the University of Edinburgh and continued with three Postdoctoral Fellowships and a position as a Clinical Studies Officer within the NHS Scotland. Mario was as an Assistant Professor in Psychology at Heriot-Watt University, Edinburgh from 2015 until 2018 before joining the University of Strathclyde.
Dr Terry Quinn
Terry holds the post of Senior Clinical Lecturer and Honorary Consultant Physician in Stroke. Terry has a broad research portfolio, his principal research interests are around trial methodology, functional assessment and neuropsychological consequences of cardiovascular disease.
Terry has published extensively on topics relating to stroke, cognition and test accuracy and has authored original research, opinion pieces and editorials for journals such as British Medical Journal; Journal of the American Medical Association and New England Journal of Medicine.
He is Principal Investigator for a number of studies and holds the inaugural CSO/Stroke Association priority program grant for his research into cognitive outcomes following stroke.
Terry is passionate about evidence based practice and has worked to raise standards in clinical research involving older adults. He holds editorial board positions with various journals, he is coordinating editor for the Cochrane Dementia Group; member of the Dementia Platforms UK vascular theme and part of the NIHR Complex Reviews Support Unit.
Communicating science is a particular strength and in his role working with patient, carers and lay public, as lead for the Scottish Stroke Research Network he has initiated a number of schemes around research dissemination and involvement. As clinical member of the Scottish Parliament Cross Party Group on Heart Disease and Stroke and advisor to Healthcare Improvement Scotland, Terry has ensured that research results inform policy. A recent example is his role as medical advisor to the National report on atrial fibrillation.
Terry combines his research portfolio with active teaching and clinical commitments in the stroke units of the major Glasgow hospitals.
Professor Alison Murray
Alison is the Roland Sutton Professor of Radiology at the University of Aberdeen. She is Director of the Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE) a brain imaging pooling initiative, an executive member of the Scottish Dementia Research Consortium and past-president of the Scottish Radiological Society.
Alison leads NHS molecular brain imaging in people with neurodegenerative diseases and dementia. She has a track record of brain magnetic resonance imaging research in the Aberdeen Birth Cohorts on factors that increase risk of cognitive impairment and conversely, what provides resilience to decline.
She is passionate about the influence of early-life socioeconomic circumstance on late-life brain health
Fraser is a PhD student within the Institute of Cardiovascular and Medical Sciences at the University of Glasgow. He is working on data from the XILO-FIST clinical trial, a study which investigates the affect of allopurinol on long-term outcomes following ischaemic stroke.
Fraser is interested in exploring the relationship between carotid artery structure, brain structure and cognition in ischaemic stroke, and developing an automated tool that will estimate vascular parameters of carotid structure including stenosis.
Additionally, he aims to investigate any effects allopurinol has on carotid artery structure, including percentage of stenosis and intima-media thickness
Miles has a BSc and MSc in psychology which has led onto undertaking a PhD studying the individual differences in the causes and consequences of ageing.
In particular Miles is interested in the occurrence of frailty in later life and the risk and preventative factors associated with this.
Frailty can affect a vast number of people and being able to identify those who are at highest risk is a crucial step for us to be able to get people on a healthier trajectory with a lower risk of frailty and subsequently a lower risk of disease, disability and death.